Related Experiment Video

Updated: Dec 6, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.5K

COVID-19 and VIH

María Paulina Posada-Vergara1, Juan Carlos Alzate-Ángel1,2, Ernesto Martínez-Buitrago1,3,4,5

  • 1Grupo VIHCOL, Cali, Colombia.

Colombia Medica (Cali, Colombia)
|October 5, 2020
PubMed

Insights

People with HIV did not experience worse COVID-19 outcomes than expected, despite immunosuppression. Research explores factors like antiretrovirals and offers prevention strategies for HIV-COVID-19 co-infection.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • COVID-19 disproportionately affects individuals with comorbidities like diabetes, obesity, and cardiovascular disease.
  • Persons with human immunodeficiency virus (HIV) were anticipated to face severe COVID-19 due to immunosuppression.
  • Observed outcomes in HIV-positive individuals during the pandemic have presented a paradox, prompting further investigation.

Purpose of the Study:

  • To review the epidemiology and clinical characteristics of COVID-19 in individuals with HIV.
  • To discuss potential factors, including antiretroviral therapy, influencing the clinical course of HIV-COVID-19 co-infection.
  • To analyze pandemic-related risks for people with HIV and provide care recommendations.

Main Methods:

  • Literature review of existing data on HIV-COVID-19 co-infection.
  • Analysis of epidemiological trends and clinical outcomes.
  • Synthesis of evidence regarding influencing factors and risk determinants.

Main Results:

  • Contrary to expectations, persons with HIV have not shown a consistently higher susceptibility or poorer outcomes for COVID-19.
  • Hypotheses regarding the protective role of immunosuppression or antiretroviral use are being explored.
  • Other pandemic-related factors may negatively impact individuals with HIV.

Conclusions:

  • The clinical evolution of COVID-19 in people with HIV requires further study to understand the observed paradox.
  • Evidence-based recommendations are needed for the prevention and management of COVID-19 in the context of HIV care.
  • Understanding these dynamics is crucial for optimizing public health strategies during pandemics.

Keywords:
COVID-19HIVSARS viruscoinfection

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.7K
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.5K

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
677
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
579
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.3K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
99